-
Vieussens
R. Nouvelles Découvertes sur le coeur. Paris 1706.
-
Thebesius
AC. Disputatio medica de circulo sanguinis in corde. Lugduni
Batavorum 1708.
-
Wearn
JT, Mettier SR, Klump TG, Zschiesche AB. The nature of the
vascular communications
between the coronary arteries and the chambers of the heart.
Am Heart J 1933;9:143-70. Wearn 1933.
-
Tsang
JC-C, Chiu RC-J. The phantom of "myocardial sinusoids:" a
historical reappraisal. Ann Thorac Surg. 1995;60:1831-5.
-
Jensen
D. The hagfish. Sci. Am 1966;214:82-90.
-
Webb
GJW. Comparative anatomy of the reptilia. III. The heart of
crocodilians and a hypothesis
on the completion of the interventricular septum of crocodilians
and birds. J Morphol 1979;161:221-40.
- Bonnet
D., Gautier-Lhermitte I., Bonhoeffer P, Sidi D. Right ventricular
myocardial sinusoidal-
coronary artery connections in critical pulmonary valve stenosis.
Pediatric Cardiology; 1998:
269-71.
- Vineberg
AM. Development of an anastomosis between the coronary vessels
and a transplanted internal mammary artery. Can Med Assoc J
1946;55:117-9.
- Pifarré
R, Wilson SM, LaRossa DD, Hufnagel CA. Myocardial revascularization:
arterial and venous implants. J Thorac Cardiovasc Surg 1968;55(3):309-19.
- Goldman
A, Greenstone SM, Preuss FS, Strauss SH, Chang ES. Experimental
methods for producing a collateral circulation of the heart
directly from the left ventricle. J Thorac Surg 1956;31:364-74.
- Sen PK,
Daulatram J, Kinare SG, Udwadia TE, Parulkar GB. Further studies
in multiple transmyocardial acupuncture as a method of myocardial
revascularization. Surgery 1968;64(5): 861-70.
- White M
and Hershey JE. Multiple transmyocardial puncture revascularization
in refractory ventricular fibrillation due to myocardial ischemia.
Ann Thorac Surg 1968;6(6):557-63.
- Pifarré
R, Jasuja ML, Lynch RD, Neville WE. Myocardial revascularization
by transmyocardial acupuncture: a physiologic impossibility.
J Thorac Cardiovasc Surg 1969;58:424-31.
- Massimo
C, Boffi L. Myocardial revascularization by a new method of
carrying blood directly from the left ventricular cavity into
the coronary circulation. J Thorac Surg 1957;34:257-64.
- Mirhoseini
M, Cayton MM: Revascularization of the heart by laser. J Microsurg
2:253-60, 1981.
- Mirhoseini
M, Shelgikar S, Cayton MM. New concepts in revascularization
of the myocardium. Ann Thorac Surg 1988; 45:415-20.
- Okada M,
Ikuta H, Shimizu K, Horii H, Nakamura K. Alternate method of
myocardial revascularization by laser: experimental and clinical
study. Kobe J Med Sci 1986;32:151-61.
- Burkhoff
D, Fisher PE, Apfelbaum M, Kohmoto T, DeRosa CM, Smith CR. Histologic
appearance of transmyocardial laser channels after 4 1/2 weeks.
Ann Thorac Surg 1996;61(5):1532-4.
Increased
photo acoustic and thermal damage seen acutely after Ho:YAG
TMR vs. CO2 TMR.
- Krabatsch
T, Schaper F, Leder C, Tulsner J, Thalmann U, Hetzer R. Histological
findings after transmyocardial laser revascularization. J Card
Surg 1996;11(5):326-31.
- Gassler
N, Wintzer HO, Stubbe HM, Wullbrand A, Helmchen U. Transmyocardial
laser revascularization. Histological features in human nonresponder
myocardium. Circulation 1997;95(2):371-5.
Correlation
of lack of channel patency with lack of symptom relief in
an autopsy series.
- Malekan
R, Reynolds C, Kelley ST, Suzuki Y, Bridges CR. Angiogenesis
in transmyocardial laser revascularization: a non-specific response
to injury. Circulation 1998;98(19):II-62-5.
CO2
TMR and mechanical TMR produce similar histologic evidence
of angiogenesis in normal ovine myocardium.
- Malekan
R, Kelley ST, Suzuki Y, et al. Transmyocardial laser revascularization
fails to prevent left ventricular functional deterioration and
aneurysm formation after acute myocardial infarction in sheep.
J Thorac Cardiovasc Surg 1998;116:752-62.
- Chu V,
Giaid A, Kuang J, et al. Angiogenic response to transmyocardial
revascularization (TMR): laser versus mechanical punctures.
Ann Thorac Surg (in press 1999).
- Kohmoto
T, Fisher P, Gu A, et al. Physiology, histology, and 2-week
morphology of acute transmyocardial channels made with a CO2
laser. Ann Thorac Surg 1997;63(5):1275-83.
- Kohmoto
T, Fisher P, Gu A, et al. Does blood flow through Holmium: YAG
transmyocardial channels? Ann Thorac Surg 1996; 61:861-8.
No
significant perfusion noted in a canine model after Ho:YAG
TMR.
- Kohmoto
T, DeRosa CM, Yamamoto N, et al. Evidence of vascular growth
associated with laser treatment of normal canine myocardium.
Ann Thorac Surg 1998;65(5):1360-7.
- Fisher
PE, Kohmoto T, DeRosa CM, Spotnitz HM, Smith CR, Burkhoff D.
Histologic analysis of transmyocardial channels: comparison
and CO2 and holmium:YAG lasers: Ann Thorac Surg 1997;65(2):466-72.
- Yamamoto
N, Kohmoto T, Gu A, DeRosa C, Smith CR, Burkhoff D. Angiogenesis
is enhanced in ischemic canine myocardium by transmyocardial
laser revascularization. J Am Coll Cardiol 1998;31(6):1426-33.
- Fleischer
KJ, Goldschmidt-Clermont PJ, Fonger JD, Hutchins GM, Hruban
RH, Baumgartner WA. One-month histologic response of transmyocardial
laser channels with molecular intervention. Ann Thorac Surg.
1996;62:1051-8.
- Zlotnick
AY, Ahmad RM, Reul RM, Laurence RG, Aretz HT, Cohn LH. Neovascularization
occurs at the
site of closed laser channels after transmyocardial laser revascularization.
Surg Forum 1996; XLVII:286-87.
- Chu VF,
Giaid A, Kuang JQ, McGinn AN, Li CM, Pelletier MP, Chiu RC.
Thoracic Surgery Directors Association Award. Angiogenesis in
transmyocardial revascularization: comparison of laser versus
mechanical punctures. Ann Thorac Surg. 1999;68(2):301-7.
- Jeevanandam
V, Auteri JS, Oz MC, Watkins J, Rose EA, Smith CR. Myocardial
revascularization by laser induced channels. Surgical Forum
1990;41:225-27.
- Yano OJ,
Bielefeld MR, Jeevanandam V, et al. Prevention of acute regional
ischemia with endocardial laser channels. Ann Thorac Surg 1993;56:
46-53.
- Lee LY,
O'Hara MF, Finnin EB, Hachamovitch R, Szulc M, Kligfield PD,
Okin PM, Isom OW, Rosengart TK. Transmyocardial laser revascularization
with excimer laser: clinical results at 1 year. Ann Thorac Surg
2000;70(2):498-503.
- Horvath
KA, Cohn LH, Cooley DA, et al. Transmyocardial laser revascularization:
results of a multicenter trial with transmyocardial laser revascularization
used as sole therapy for end-stage coronary artery disease.
J Thorac Cardiovasc Surg 1997;113(4):645-53.
- Schofield,
PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularization
in patients with refractory angina: a randomised controlled
trial. Lancet 1999;353:519-24.
Trial
of 188 patients prospectively randomized to TMR or medical
therapy in which exercise tolerance time, walk distance and
angina reduction was seen in TMR patients but not in those
treated medically.
- Cooley
DA, Frazier OH, Kadipasaoglu KA, et al. Transmyocardial laser
revascularization: clinical experience with twelve-month follow-up.
J Thorac Cardiovasc Surg 1996;111:791-9.
- Donovan
CL, Landolfo KP, Lowe JE, Clements F, Coleman RB, Ryan T. Improvement
in inducible ischemia during dobutamine stress echocardiography
after transmyocardial laser revascularization patients with
refractory angina pectoris. J Am Coll Card 1997;30(3):607-12.
Improved
myocardial function after sole therapy CO2 TMR.
- Frazier
OH, Cooley DA, Kadipasaoglu KA, et al. Myocardial revascularization
with laser: Preliminary findings. Circulation 1995;92 (Suppl
II) :II-58-65.
- Horvath
KA, Mannting F, Cummings N, Sherman SK, Cohn LH. Transmyocardial
laser revascularization: Operative techniques and clinical results
at two years. J Thorac Cardiovasc Surg 1996;111:1047-53.
- Krabatsch
T, Tambeur L, Lieback E, Shaper F, Hetzer R. Transmyocardial
laser revascularization in the treatment of end-stage coronary
artery disease. Ann Thorac Cardiovasc Surg 1998;4:64-71.
- Lutter
G, Sauerbier B, Nitzsche E, et al. Transmyocardial laser revascularization
(TMLR) in patients with unstable angina and low ejection fraction.
Euro J Cardio-Thoracic Surg 1998;13:21-6.
- Milano
A, Pratali S, Tartarini G, et al. Early results of transmyocardial
revascularization with a holmium laser. Ann Thorac Surg 1998;65:700-4.
- Aaberge
L, Nordstrand K, Dragsund M, Saatvedt K, Endresen K, Golf GO,
Abdelnoor M, Forfang K. Transmyocardial revascularization with
CO2 laser in patients with refractory angina pectoris. Clinical
results from the Norwegian randomized trial. J Am Coll Cardiol
2000;35(5):1170--7.
- Aaberge
L, Rootwelt K, Blomhoff S, Saatvedt K, Abdelnoor M, Forfang
K. Continued symptomatic improvement three to five years after
transmyocardial revascularization with CO2 laser: a late clinical
follow-up of the Norwegian randomized trial with transmyocardial
revascularization. j Am Coll Cardiol. 2002; 39:1588-93.
Significant
long-term sustained angina reduction and fewer hospitalizations
were seen in patients treated with CO2 TMR. As an extension
of the randomized trial, the medical management cohort provides
a long-term control group.
- Allen KB,
Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization
with medical therapy in patients with refractory angina. N Engl
J Med 1999;341:1029-36.
Prospective
randomized controlled trial of 275 patients who had either
Ho:YAG TMR or medical management. At one year 76% of the patients
in the TMR group had significant angina reduction compared
to 32% of the medical management group. No change in myocardial
perfusion noted post-treatment.
- Burkhoff
D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LC, Weiss
J, Jones JW. Transmyocardial laser revascularization compared
with continued medical therapy for treatment of refractory angina
pectoris: a prospective randomized trial. Lancet 1999;354:885--90.
182 patients prospectively randomized to Ho:YAG TMR or medical
management. At one year, exercise tolerance was increased by
65 seconds in the TMR group with a 46 second decrease in the
medical management group. Significant angina reduction was seen
in 48% of the TMR group compared to 14% of the medical management
group. Significant quality of life improvements were noted after
TMR treatment as well.
- Frazier
OH, March RJ, Horvath KA. Transmyocardial revascularization
with a carbon dioxide laser in patients with end-stage coronary
artery disease. N Engl J Med 1999;341:1021-8.
Prospective
randomized controlled trial of 192 patients treated with either
CO2 TMR or medical management. 72% had significant angina
reduction as compared to 13% of the medical management cohort.
Myocardial perfusion was improved after CO2 TMR. Quality of
life was also significantly improved for TMR patients, although
there was no difference in one-year survival.
- Horvath
KA, Aranki SF, Cohn LH, March RJ, Frazier OH, Kadipasaoglu KA,
Boyce SW, Lytle BW, Landolfo KP, Lowe JE, Hattler B, Griffith
BP, Lansing AM. Sustained angina relief 5 years after transmyocardial
laser revascularization with CO2 Laser. Circulation. 2001;104(12):I81-84.
Angina
improvement at one year maintained beyond five years after
CO2 TMR. Similar improvements in quality of life were noted
to be sustained.
- Horvath
KA, Cohn LC, Cooley DA, Crew JR Frazier OH, Griffith BP, Kadipasaoglu
K, Lansing A, Mannting FR, March R, Mirhoseini MR, Smith C.
Transmyocardial laser revascularization: results of multi-center
trial using TLR as sole therapy for end stage coronary artery
disease. J Thorac Cardiovasc Surg 1997;113:645--54.
- De Carlo
M, Milano AD, Pratali S, Levantino M, Mariotti R, Bortolotti
U. Symptomatic improvement after transmyocardial laser revascularization:
how long does it last? Ann Thorac Surg 2000;70:1130-33.
Angina recurred at a significant rate 3 years after Ho:YAG TMR.
- Stamou
SC, Boyce SW, Cooke RH, Carlos BD, Sweet LC, Corso PJ. One-year
outcome after combined coronary artery bypass grafting and transmyocardial
laser revascularization for refractory angina pectoris. Am J
Cardiol 2002;89(12):1365-8.
Outcomes
of 169 patients who underwent combined CABG and TMR. Significant
angina reduction with only 4% in angina class III or IV at
12 months. Age greater than 75, prolonged intensive care unit
stay and in-hospital myocardial infarction were predictors
of major adverse events.
- Mack CA,
Magovern CJ, Hahn RT, et al. Channel patency and neovascularization
after transmyocardial revascularization using an excimer laser:
results and comparison to nonlased channels. Circulation 1997;96(Suppl
II):II-65-9.
- Pelletier
MP, Giaid A, Sivaraman S, et al. Angiogenesis and growth factor
expression in a model of transmyocardial revascularization.
Ann Thorac Surg 1998;66:12-8.
- Horvath
KA, Chiu E, Maun DC, Lomasney JW, Greene R, Pearce WH, Fullerton
DA. Up-regulation of VEGF mRNA and angiogenesis after transmyocardial
laser revascularization. Ann Thorac Surg 1999;68:825-9.
TMR
stimulates endogenous production of VEGF, which results in
angiogenesis in porcine model of chronic myocardial ischemia.
- Horvath
KA, Belkind N, Wu J, Greene R, Doukas J, Lomasney JW, McPherson
DD, Fullerton DA. Functional comparison of transmyocardial revascularization
by mechanical and laser means. Ann Thorac Surg 2001;72:1997-2002
Experimental
investigation demonstrating similar angiogenesis with laser
and mechanical TMR. Greater scar formation with various mechanical
devices and only laser TMR improves the function of chronically
ischemic myocardium.
- Kwong KF,
Kanellopoulos GK, Nickols JC, et al. Transmyocardial laser treatment
denervates canine myocardium. J Thorac Cardiovasc Surg 1997;114:883-90.
Initial
study exploring denervation as a mechanism.
-
Hirsch
GM, Thompson GW, Arora RC, Hirsch KJ, Sullivan JA, Armour
JA. Transmyocardial laser revascularization does not denervate
the canine heart. Ann Thorac Surg 1999;68(2):460-8.
-
Al-Sheikh
T, Allen KB, Straka SP, Heimansohn DA, Fain RL, Hutchins GD,
Sawada SG, Zipes DP, Engelstein ED. Cardiac sympathetic denervation
after transmyocardial laser revascularization. Circulation
1999;100:135-40
- Allen
KB, Dowling RD, DelRossi AJ, Realyvasques F, Lefrak EA, Pfeffer
TA, Fudge TL, Mostovych M, Schuch D, Szentpetery S, Shaar CJ.
Transmyocardial laser revascularization combined with coronary
artery bypass grafting: a multicenter, blinded, prospective,
randomized, controlled trial. J Thorac Cardiovasc Surg 2000;119(3):540-9.
Randomized
trial comparing CABG with CABG plus TMR demonstrated improved
30 day survival in the CABG +TMR group.
- Peterson
ED, Kaul P, Kaczmarek RG, Hammill BG, Armstrong PW, Bridges
CR, Ferguson TB. From Controlled Trials to Clinical Practice:
Monitoring Transmyocardial Revascularization Use and Outcomes.
(submitted ).
- Schneider
J, Diegeler A, Krakor R, Walther T, Kluge R, Mohr RW. Transmyocardial
laser revascularization with the holmium:YAG laser: Loss of
symptomatic improvement after 2 years. Eur J Cardio-Thorac Surg
2001;19(2):164-9.
- Tjomsland
O, Aaberge L, Almdahl S, Dragsund M, Moelstad P, Saatvedt K,
Nordstrand K. Perioperative cardiac function and predictors
for adverse events after transmyocardial laser treatment. Ann
Thorac Surg 2000;69:1098-103.
- Kadipasaoglu
K, Sartori M, Masai T, Cihan HB, Clubb FJ Jr., Conger JL, Frazier
OH. Intraoperative arrhythmias and tissue damage during transmyocardial
laser revascularization. Ann Thorac Surg 1999;67:4230-31.
Fewer arrhythmias, less necrosis seen with CO2 laser vs. Ho:YAG
laser in an experimental study.
- Hughes
GC, Landolfo KP, Lowe JE, Coleman RB, Donovan CL. Diagnosis,
incidence, and clinical significance of early postoperative
ischemia after transmyocardial laser revascularization. Am Heart
J 1999;137(6):1163-8.
- Hughes
GC, Landolfo KP, Lowe JE, Coleman RB, Donovan CL. Perioperative
morbidity and mortality after transmyocardial laser revascularization:
incidence and risk factors for adverse events. J Am Coll Cardiol
1999;33(4):1021-6.
- Hughes
GC, Shah AS, Yin B, Shu M, Donovan CL, Glower DD, Lowe JE, Landolfo
KP. Early postoperative change in regional systolic and diastolic
left ventricular function after transmyocardial laser revascularization:
a comparison of holmium:YAG and CO2 lasers. J Am Coll Cardiol.
2000;35(4):1022-30.
- Hattler
BG, Griffith BP, Zenati MA, Crew JR, Mirhoseini M, Cohn LH,
Aranki SF, Frazier OH,
Cooley DA, Lansing AM Horvath KA, Fontana GP, Landolfo KP, Lowe
JE, Boyce SW. Transmyocardial laser revascularization in the
patient with unmanageable unstable angina. Ann Thorac Surg 1999;68(4):1203-9.
- Burkhoff
D, Wesley MN, Resar JR, Lansing AM. Factors correlating with
risk of mortality after
transmyocardial revascularization. J Am Coll Cardiol 1999;34(1):55-61.
- Kraatz
EG, Misfeld M, Jungbluth B, Sievers HH. Survival after transmyocardial
laser revascularization
in relation to nonlasered perfused myocardial zones. Ann Thorac
Surg 2001;71:53206.
- Lutter
G, Saurbier B, Nitzsche E, Kletzin F, Martin J, Schlensak C,
Lutz C, Beyersdorf F. Transmyocardial laser revascularization
(TMLR) in patients with unstable angina and low ejection fraction.
Eur J Cardio-Thorac Surg 1998;13(1):21-6
- Frazier
OH, Kadipasaoglu KA, Radovancevic B, Cihan HB, March RJ, Mirhoseini
M, Cooley DA. Transmyocardial revascularization in allograft
coronary artery disease. Ann Thorac Surg 1998;65(2):1138-41.
- Horvath
KA. Thoracoscopic transmyocardial laser revascularization. Ann
Thorac Surg 1998;65:1439-41.
- Leon MB,
Daim DS, Moses JW, Laham RJ, Knopf W, Reisman M, et al. A randomized
blinded clinical trial comparing percutaneous laser myocardial
revascularization (using Biosense LV mapping) Vs placebo in
patients with refractory coronary ischemia. Circulation 2000;102(18)II:565.
- Oesterle
SN, Reifart NJ, Meier B, et al. Initial results of laser-based
percutaneous myocardial revascularization for angina pectoris.
Am J Cardiol 1998;82:659-62.
- Whittaker
P, Zheng S, Patterson MJ, Kloner RA, Daly KE, Hartman RA. Histologic
signatures of thermal injury: applications in transmyocardial
laser revascularization and radiofrequency ablation. Laser Surg
Med 2000;27:305-18
- Krabatsch
T, Petzina R, Baretti R, Hausmann H, Hetzer R. Extent of myocardial
tissue damage during transmyocardial laser revascularization
with the CO2 Heart Laser. J Clin Laser Med & Surg 2001;19(5):251-9.
- Yamamoto
N, Kohmoto T, Roethy W, Gu A, DeRossa C, Rabbani LE, Smith CR,
Burkhoff D. Histologic evidence that basic fibroblast growth
factor enhances the angiogenic effects of transmyocardial laser
revascularization. Basic Research in Cardiology 2000;95(1):55-63.
- Sayeed-Shah
U, Reul RM, Byrne JG, Aranki SF, Cohn LH. Combination TMR and
gene therapy. Seminars in Thoracic & Cardiovascular Surgery
1999;11(1):36-9.
|
|
